Worldwide, the number of infections caused by biofilm-forming fungal pathogens is very
high. In human medicine, there is an increasing proportion of immunocompromised patients …

Effective management and treatment of fungal diseases is hampered by poor diagnosis,
limited options for antifungal therapy, and the emergence of antifungal drug resistance. An …

Candida auris is an opportunistic fungal pathogen and an emerging global public health
threat, given its high mortality among infected individuals, antifungal resistance, and …

Candida auris is a novel and major fungal pathogen that has triggered several outbreaks in
the last decade. The few drugs available to treat fungal diseases, the fact that this yeast has …

Candida auris was first described as a yeast pathogen in 2009. Since then, the species has
emerged worldwide. In contrast to most other Candida spp., C. auris frequently exhibits multi …

Candidiasis is a highly pervasive infection posing major health risks, especially for
immunocompromised populations. Pathogenic Candida species have evolved intrinsic and …

Fungal infections cause severe and life-threatening complications especially in
immunocompromised individuals. Antifungals targeting cellular machinery and cell …

The two fungal human pathogens, Candida auris and Candida albicans, possess a variety
of virulence mechanisms. Among them are the formation of biofilms to protect yeast against …

Candida auris was first detected at a university-affiliated hospital in Johannesburg, South
Africa, in 2009. We used whole-genome sequencing to describe the molecular …

Since its first description in 2009, Candida auris has, so far, resulted in large hospital
outbreaks worldwide and is considered an emerging global public health threat …